Dabigatran etexilate (Pradaxa), an anticoagulant, works by:
A. inhibiting factor II (thrombin).
B. inhibiting the activation of vitamin K-dependent clotting factors II, VII, IX and X.
C. inhibition of factor Xa.
D. binding to antithrombin Ill to enhance the rate of neutralization of factors Il (thrombin) and Xa.

Respuesta :

Otras preguntas